182 related articles for article (PubMed ID: 28277090)
1. Serological response to trivalent inactivated influenza vaccine in HIV-infected adults in Singapore.
Lau YF; Tang LH; Chien Lye D; Ooi EE; Leo YS
Hum Vaccin Immunother; 2017 Mar; 13(3):551-560. PubMed ID: 28277090
[TBL] [Abstract][Full Text] [Related]
2. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
[TBL] [Abstract][Full Text] [Related]
3. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
4. Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza.
Rinaldi S; Zangari P; Cotugno N; Manno EC; Brolatti N; Castrucci MR; Donatelli I; Rossi P; Palma P; Cagigi A
Vaccine; 2014 Feb; 32(6):657-63. PubMed ID: 24333344
[TBL] [Abstract][Full Text] [Related]
5. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR
Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection.
Hakim H; Allison KJ; Van de Velde LA; Tang L; Sun Y; Flynn PM; McCullers JA
Vaccine; 2016 Jun; 34(27):3141-3148. PubMed ID: 27129426
[TBL] [Abstract][Full Text] [Related]
7. Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons: a single-center, parallel, randomized trial.
McKittrick N; Frank I; Jacobson JM; White CJ; Kim D; Kappes R; DiGiorgio C; Kenney T; Boyer J; Tebas P
Ann Intern Med; 2013 Jan; 158(1):19-26. PubMed ID: 23277897
[TBL] [Abstract][Full Text] [Related]
8. Randomized Controlled Trial to Compare Immunogenicity of Standard-Dose Intramuscular Versus Intradermal Trivalent Inactivated Influenza Vaccine in HIV-Infected Men Who Have Sex With Men in Bangkok, Thailand.
Garg S; Thongcharoen P; Praphasiri P; Chitwarakorn A; Sathirapanya P; Fernandez S; Rungrojcharoenkit K; Chonwattana W; Mock PA; Sukwicha W; Katz JM; Widdowson MA; Curlin ME; Gibbons RV; Holtz TH; Dawood FS; Olsen SJ
Clin Infect Dis; 2016 Feb; 62(3):383-391. PubMed ID: 26486702
[TBL] [Abstract][Full Text] [Related]
9. Humoral immune response following the inactivated quadrivalent influenza vaccination among HIV-infected and HIV-uninfected adults.
Liu Z; Pang C; Deng Y; Guo C; Li J; Li Y; Xin R; Li X; Xu C; Huang C; Lu H; Li J
Vaccine; 2023 Jul; 41(34):4978-4985. PubMed ID: 37394372
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers.
Low JG; Lee LS; Ooi EE; Ethirajulu K; Yeo P; Matter A; Connolly JE; Skibinski DA; Saudan P; Bachmann M; Hanson BJ; Lu Q; Maurer-Stroh S; Lim S; Novotny-Diermayr V
Vaccine; 2014 Sep; 32(39):5041-8. PubMed ID: 25045806
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children.
Phongsamart W; Sirisanthana V; Wittawatmongkol O; Maleesatharn A; Sudjaritruk T; Chearskul P; Aurpibul L; Sirisanthana T; Chokephaibulkit K
Vaccine; 2011 Nov; 29(47):8705-11. PubMed ID: 21893147
[TBL] [Abstract][Full Text] [Related]
12. Standard-Dose Intradermal Influenza Vaccine Elicits Cellular Immune Responses Similar to Those of Intramuscular Vaccine in Men With and Those Without HIV Infection.
Amoah S; Mishina M; Praphasiri P; Cao W; Kim JH; Liepkalns JS; Guo Z; Carney PJ; Chang JC; Fernandez S; Garg S; Beacham L; Holtz TH; Curlin ME; Dawood F; Olsen SJ; Gangappa S; Stevens J; Sambhara S
J Infect Dis; 2019 Jul; 220(5):743-751. PubMed ID: 31045222
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and sustainability of the immune response in Brazilian HIV-1-infected individuals vaccinated with inactivated triple influenza vaccine.
Souza TM; Santini-Oliveira M; Martorelli A; Luz PM; Vasconcellos MT; Giacoia-Gripp CB; Morgado M; Nunes EP; Lemos AS; Ferreira AC; Moreira RI; Veloso VG; Siqueira M; Grinsztejn B; Camacho LA
J Med Virol; 2016 Mar; 88(3):426-36. PubMed ID: 26267817
[TBL] [Abstract][Full Text] [Related]
14. Comparison of hemagglutination inhibition and microbead array assays for the measurement of influenza antibody levels in HIV-infected adults.
Thorne A; Chowdhury F; Singer J; Keynan Y; Fowke KR; Cooper C;
Vaccine; 2016 Jun; 34(31):3584-91. PubMed ID: 27211040
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial.
Belshe RB; Frey SE; Graham IL; Anderson EL; Jackson LA; Spearman P; Edupuganti S; Mulligan MJ; Rouphael N; Winokur P; Dolor RJ; Woods CW; Walter EB; Chen WH; Turley C; Edwards KM; Creech CB; Hill H; Bellamy AR;
JAMA; 2014 Oct; 312(14):1420-8. PubMed ID: 25291578
[TBL] [Abstract][Full Text] [Related]
16. Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children.
Gilca V; De Serres G; Hamelin ME; Boivin G; Ouakki M; Boulianne N; Sauvageau C; Dionne M; Gilca R; Skowronski D
Vaccine; 2011 Dec; 30(1):35-41. PubMed ID: 22063386
[TBL] [Abstract][Full Text] [Related]
17. Safety, immunogenicity and shedding of LAIV4 in HIV-infected and uninfected children.
Curtis D; Ning MF; Armon C; Li S; Weinberg A
Vaccine; 2015 Sep; 33(38):4790-7. PubMed ID: 26241950
[TBL] [Abstract][Full Text] [Related]
18. Antibody response to the influenza vaccine in healthcare workers.
Sacadura-Leite E; Sousa-Uva A; Rebelo-de-Andrade H
Vaccine; 2012 Jan; 30(2):436-41. PubMed ID: 22064268
[TBL] [Abstract][Full Text] [Related]
19. Antibody responses to trivalent influenza vaccine in Iranian adults infected with human immunodeficiency virus.
Rasoolinejad M; Jafari S; Montazeri M; Mohseni M; Foroughi M; Moradmand Badie B; Saatian M; Marashi SM; Mokhtari Azad T
Acta Med Iran; 2013 Apr; 51(3):148-52. PubMed ID: 23605597
[TBL] [Abstract][Full Text] [Related]
20. Influenza vaccination in children primed with MF59-adjuvanted or non-adjuvanted seasonal influenza vaccine.
Vesikari T; Forstén A; Arora A; Tsai T; Clemens R
Hum Vaccin Immunother; 2015; 11(8):2102-12. PubMed ID: 26091244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
